ETON PHARMACEUTICALS INC. - COMMON STOCK

Eton Pharmaceuticals Awarded U.S. Patent for Proprietary Hydrocortisone Oral Liquid Formulation

21 Feb 2024 05:50:00 By Nasdaq GlobeNewswire

Eton Pharmaceuticals Announces Commercial Availability of Ultra-Rare Disease Product Nitisinone Capsules

02 Feb 2024 05:50:00 By Nasdaq GlobeNewswire

Eton Pharmaceuticals Reports Third Quarter 2023 Financial Results

09 Nov 2023 15:01:00 By Nasdaq GlobeNewswire

Eton Pharmaceuticals to Report Third Quarter 2023 Financial Results on Thursday, November 9, 2023

30 Oct 2023 05:50:00 By Nasdaq GlobeNewswire

Eton Pharmaceuticals Announces Acquisition of FDA-Approved Ultra-Rare Disease Product Nitisinone

04 Oct 2023 05:50:00 By Nasdaq GlobeNewswire

Eton Pharmaceuticals to Present at the H.C. Wainwright 25th Annual Global Investment Conference

23 Aug 2023 05:50:00 By Nasdaq GlobeNewswire

Eton Pharmaceuticals Reports Second Quarter 2023 Financial Results

10 Aug 2023 15:01:00 By Nasdaq GlobeNewswire

Eton Pharmaceuticals to Report Second Quarter 2023 Financial Results on Thursday, August 10, 2023

01 Aug 2023 15:05:00 By Nasdaq GlobeNewswire

Eton Pharmaceuticals Receives Complete Response Letter (CRL) for Dehydrated Alcohol Injection

28 Jun 2023 05:50:00 By Nasdaq GlobeNewswire

Eton Pharmaceuticals Reports First Quarter 2023 Financial Results

11 May 2023 15:01:01 By Nasdaq GlobeNewswire

Eton Pharmaceuticals Announces Commercial Availability of Betaine Anhydrous for Oral Solution, a Generic Version of Cystadane® (betaine anhydrous for oral solution)

10 May 2023 05:50:00 By Nasdaq GlobeNewswire

Eton Pharmaceuticals to Report First Quarter 2023 Financial Results on Thursday, May 11, 2023

03 May 2023 15:05:00 By Nasdaq GlobeNewswire

Eton Pharmaceuticals Reports Fourth Quarter 2022 Financial Results

16 Mar 2023 15:01:00 By Nasdaq GlobeNewswire

Eton Pharmaceuticals Announces Acquisition of Rare Disease Product Candidate ET-600

15 Mar 2023 05:50:00 By Nasdaq GlobeNewswire

Eton Pharmaceuticals to Report Fourth Quarter 2022 Financial Results on Thursday, March 16, 2023

07 Mar 2023 15:05:00 By Nasdaq GlobeNewswire

Eton Pharmaceuticals Announces FDA Acceptance of NDA Response for Dehydrated Alcohol Injection

11 Jan 2023 05:50:00 By Nasdaq GlobeNewswire

Eton Pharmaceuticals Reports Third Quarter 2022 Financial Results

10 Nov 2022 15:05:01 By Nasdaq GlobeNewswire

Eton Pharmaceuticals to Report Third Quarter 2022 Financial Results on Thursday, November 10, 2022

02 Nov 2022 15:05:00 By Nasdaq GlobeNewswire

Eton Pharmaceuticals to Present at the LD Micro Main Event XV Conference

18 Oct 2022 05:50:00 By Nasdaq GlobeNewswire

Eton Pharmaceuticals Announces Acquisition of FDA-Approved Rare Disease Product, Betaine Anhydrous for Oral Solution

13 Sep 2022 08:00:01 By Nasdaq GlobeNewswire